Biopticon Corporation leads the industry with their Tumor Management System: the TumorImager 2™, a 3D scanning device for tumor measurement, and the TumorManager™ software for xenograft study management.
The new TumorImager 2™, our second generation scanning device for subcutaneous tumor measurements on small animals delivers accurate results like its predecessor, can be quickly converted between a hand-held and hands-free scanner, and produces real color images of tumor scans. Furthermore TumorImager-2 is more accessible through much lower pricing.
A comprehensive pre-clinical oncology study management program that manages every aspect from protocol design to statistical analysis to final reporting. Comprehensive animal study management from study design and data capture to analysis and reporting final results.